NOV Capital Surpluse from 2010 to 2025

NOV Stock  USD 15.46  0.34  2.25%   
NOV Capital Surpluse yearly trend continues to be fairly stable with very little volatility. Capital Surpluse will likely drop to about 9.3 B in 2025. During the period from 2010 to 2025, NOV Capital Surpluse regression line of quarterly data had mean square error of 180447.5 T and geometric mean of  8,620,020,354. View All Fundamentals
 
Capital Surpluse  
First Reported
2009-06-30
Previous Quarter
8.8 B
Current Value
8.8 B
Quarterly Volatility
502.7 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check NOV financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NOV's main balance sheet or income statement drivers, such as Depreciation And Amortization of 369.4 M, Interest Expense of 48.6 M or Total Revenue of 8.9 B, as well as many indicators such as Price To Sales Ratio of 0.61, Dividend Yield of 0.0153 or PTB Ratio of 0.85. NOV financial statements analysis is a perfect complement when working with NOV Valuation or Volatility modules.
  
Check out the analysis of NOV Correlation against competitors.

Latest NOV's Capital Surpluse Growth Pattern

Below is the plot of the Capital Surpluse of NOV Inc over the last few years. It is NOV's Capital Surpluse historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NOV's overall financial position and show how it may be relating to other accounts over time.
Capital Surpluse10 Years Trend
Slightly volatile
   Capital Surpluse   
       Timeline  

NOV Capital Surpluse Regression Statistics

Arithmetic Mean8,633,123,214
Geometric Mean8,620,020,354
Coefficient Of Variation5.83
Mean Deviation347,263,616
Median8,591,000,000
Standard Deviation503,463,012
Sample Variance253475T
Range2.1B
R-Value0.58
Mean Square Error180447.5T
R-Squared0.34
Significance0.02
Slope61,257,899
Total Sum of Squares3802125.1T

NOV Capital Surpluse History

20259.3 B
202410.1 B
20228.8 B
20218.7 B
20208.6 B
20198.5 B
20188.4 B

About NOV Financial Statements

NOV investors use historical fundamental indicators, such as NOV's Capital Surpluse, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in NOV. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Capital Surpluse10.1 B9.3 B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for NOV Stock Analysis

When running NOV's price analysis, check to measure NOV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NOV is operating at the current time. Most of NOV's value examination focuses on studying past and present price action to predict the probability of NOV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NOV's price. Additionally, you may evaluate how the addition of NOV to your portfolios can decrease your overall portfolio volatility.